|
|
Line 186: |
Line 186: |
| <article> | | <article> |
| The meaning of the matching step is to match the amino acids which constrains to the ligand, following specific constrains which ensure that the result is sensible and feasible. For this, ROSETTA analyzes the structural formula of the non- canonical amino acid and offers the possible hydrogen binding partners. </br> | | The meaning of the matching step is to match the amino acids which constrains to the ligand, following specific constrains which ensure that the result is sensible and feasible. For this, ROSETTA analyzes the structural formula of the non- canonical amino acid and offers the possible hydrogen binding partners. </br> |
− | <p><b>Matching step inputs</b></p> | + | <h4>Matching step inputs</h4> |
| For the matching step, the following input-files are needed: | | For the matching step, the following input-files are needed: |
| <ul> | | <ul> |
Line 317: |
Line 317: |
| <article>The output for the design step is a “.pdb”-file containing the mutated scaffold and a “.score”-file. | | <article>The output for the design step is a “.pdb”-file containing the mutated scaffold and a “.score”-file. |
| For every PDB-file, a line in the score-file is generated, so it is easy to evaluate the given structure. | | For every PDB-file, a line in the score-file is generated, so it is easy to evaluate the given structure. |
− | The first score in the file is the total score of the model. After that, the number of hydrogen bonds in the protein as a whole and in the constraints is listed, followed by the number of dismissed polars in the catalytic residues as well in the whole protein and in the constraints. | + | The first score in the file is the total score of the model. After that, the number of hydrogen bonds |
| + | in the protein as a whole and in the constraints is listed, followed by the number of dismissed polars in the catalytic residues as well in the whole protein and in the constraints. |
| See the technical details below for a full overview of the output information </br> | | See the technical details below for a full overview of the output information </br> |
| <a class="hidden-expand">TECHNICAL DETAILS</a></article> | | <a class="hidden-expand">TECHNICAL DETAILS</a></article> |
Line 337: |
Line 338: |
| </div> | | </div> |
| </div> | | </div> |
− | <p><b>Our results for this step</b></p> | + | <h4>Our results for this step</h4> |
− | We choose our synthetases because of a good total score and a good ligand score. We checked the corresponding PDB-files, and rated the ligand and the binding pocket as satisfying, so that the ligand assumedly does not collide with residues in the near environment. | + | We choose our synthetases because of a good total score and a good ligand score. We checked the corresponding PDB-files, and rated the ligand and the binding pocket |
− | The total scores for CBT are not as good as the scores for NPA. However, the ligand scores are acceptable in both cases. A visual evaluation confirms that the ligand fits into the binding pocket. </br> | + | as satisfying, so that the ligand assumedly does not collide with residues in the near environment. |
| + | The total scores for CBT are not as good as the scores for NPA. However, the ligand scores are acceptable in both cases. A visual evaluation confirms that the ligand |
| + | fits into the binding pocket. </br> |
| Our results for this step </br> | | Our results for this step </br> |
− | We used this algorithm to simulate the evolution of the tyrosyl-tRNA with the amino acids Nitrophenylalanine and CBT-ASP. </br> | + | We used this algorithm to simulate the evolution of the tyrosyl-tRNA with the amino acids Nitrophenylalanine(NPA) and N<sup>γ</sup>‑2‑cyanobenzothiazol‑6‑yl‑L‑asparagine (CBT-asparagine). </br> |
| NPA simulation: </br> | | NPA simulation: </br> |
− | We created one .cst-file-block for the nitrogroup of NPA. Since there are two oxygen-atoms in the nitrogroup, we defined two atom nametags. As several possibilities are useful, we defined two possible constraint partners for the hydrogen bonds. The first is asparagine (N) or glutamine (Q) and the second is glycine (G). We set the possible distance to 2.8 A, as it is the optimal distance for hydrogenbonds, and a tolerance level of 0.5 A. We set the angles to 120° with a tolerance of 40°, as recommended by Florian Richter during our talk in cologne. The torsion angles were set to 180° with a tolerance of 180° and a penalty of 0, such that the torsion angles can rotate completely freely.(Richter, unpublished data) </br> | + | We created one .cst-file-block for the nitrogroup of NPA. Since there are two oxygen-atoms in the nitrogroup, |
| + | we defined two atom nametags. As several possibilities are useful, we defined two possible constraint partners |
| + | for the hydrogen bonds. The first is asparagine (N) or glutamine (Q) and the second is glycine (G). We set the |
| + | possible distance to 2.8 A, as it is the optimal distance for hydrogenbonds, and a tolerance level of 0.5 A. |
| + | We set the angles to 120° with a tolerance of 40°, as recommended by Florian Richter during our talk in cologne. |
| + | The torsion angles were set to 180° with a tolerance of 180° and a penalty of 0, such that the torsion angles can rotate |
| + | completely freely.(Richter, unpublished data) </br> |
| CBT-ASP simulation: </br> | | CBT-ASP simulation: </br> |
− | CBT-ASP can build hydrogen bonds in two ways. The first is a weak hydrogen bond on the sulphur atom and the other possibility is a normal hydrogen bond on the nitrogen (N2) after the C-gamma. We wrote three cst-files, one for a possible bond with sulpur, one for a possible bond with nitrogen, and one for both bonds. As possible corresponding amino acids, we chose serine, threonine, tyrosine, asparagine, glutamine, and glycine. </br> | + | CBT-ASP can build hydrogen bonds in two ways. The first is a weak hydrogen bond on the |
| + | sulphur atom and the other possibility is a normal hydrogen bond on the nitrogen (N2) |
| + | after the Cγ. We wrote three cst-files, one for a possible bond with sulpur, one for a |
| + | possible bond with nitrogen, and one for both bonds. As possible corresponding amino acids, we chose serine, threonine, tyrosine, asparagine, glutamine, and glycine. </br> |
| It is recommended to write a “.flags”-file, because there are several input- parameters to be defined, but it is also possible to define them via console user interface. </br> | | It is recommended to write a “.flags”-file, because there are several input- parameters to be defined, but it is also possible to define them via console user interface. </br> |
| For the categorization of the scaffold, we chose the automatic determination and set the following cuts: cut1: 6 A, cut2: 8 A, cut3: 10 A and cut4: 12 A, like the baker-lab commonly used. | | For the categorization of the scaffold, we chose the automatic determination and set the following cuts: cut1: 6 A, cut2: 8 A, cut3: 10 A and cut4: 12 A, like the baker-lab commonly used. |
Results
Results in silico
We used this algrithm to simulate the evolution of the tyrosyl-tRNA with the amino acids Nitrophenylalanine and CBT-ASP
We obtained 13 synthetase sequences for CBT-ASP, and 43 sequences for NPA, which fit well into the binding site according to the ROSETTA score.
Results in vivo
In order to test the functionality and specificity of our modeled aaRS, we translated a selection of the most promising amino acid sequences into DNA sequences optimized for E.coli and ordered them via gene synthesis. We then used a positive-negative selection system for characterization. The experiment proceeds as follows:
Due to problems with regards to the protein- and salt-concentration, we retransformed the gensyntheses which had been cloned into pSB1C3. In a next step, these syntheses were cotransformed in E.coli(BL21) with our positive selection plasmid.
With regards to CBT2, only the original colony could be transformed. From CBT4 and CBT5, were used each originally isolated clone and its retransformed counterpart.
Due to the IPTC-induced promoter, we used variants without IPTG, and with 5 mM, 10 mM, and 15 mM added IPTS for all plasmids for the kanamycine resistance.
We chose additional variants with regards to the antibiotics; one variant each of kanamycine, kanamycine and chloramphenicole, and kanamycine, chloramphenicole and tetracycline. The number of resulting colonies for each variant are summarized in figure X. Our in vivo results show that our in silico designed enzymes did not lead to a loss of functioning.
We ordered seven synthetase sequences of NPA via IDT, and four synthetase sequences of CBT-Asparagine by courtesy of Genscript, where we had previously
won a grant of 500€. Due to problems on the part of IDT, the sequences for NPA could not be synthetized. We still provide the sequences for further use below.
All further descriptions therefore refer to the synthetase sequences for CBT-Asparagine.
Unfortunately, we were not able to amplify the four sequences or clone them into the detection system pSB3T5. A test digestion revealed that the length of the
sequence in the plasmid puk57, which was the plasmid delivered by Genscript, did not correspond to the sequence length ordered. Therefore, we disregarded synthetase candidate number 1
for further tests.
For the remaining three sequences, we instead utilized the positive-negative selection plasmids for validation of our syntheses.
After the first, positive selection cycle, colonies formed only if the non-canonical amino acid was present.
Thus, through the positive selection, we could show that the synthetase did not lead to the loss of functioning of the enzyme.
To show specificity, we conducted a negative selection as well. We managed to clone the synthetases into the negative selection plasmid,
but were not able to verify this selection cycle. Therefore, further tests are needed to validate the specificity of the synthetases.
References
Liu, W., Brock, A., Chen, S., Chen, S., Schultz, P. G. ,(2007). Genetic incorporation of unnatural amino acids into proteins in mammalian cells. Nature methods, 4(3), 239-244.
Richter, F., Leaver-Fay, A., Khare, S. D., Bjelic, S., Baker, D. (2011). De novo enzyme design using Rosetta3. PloS one, 6(5): e19230.
Simons, K. T., Kooperberg, C., Huang, E., Baker, D. (1997). Assembly of protein tertiary structures from fragments with similar local sequences using simulated annealing and Bayesian scoring functions. Journal of molecular biology, 268(1), 209-225.